Richard Waldron

Richard Waldron is a C-level biotechnology executive with a strong background in executive management and financial expertise.

With experience as a chief financial officer and interim co-president in the biotechnology sector, he has managed multiple functions and completed over 45 corporate finance transactions.

His specialties include corporate finance, strategic planning, corporate partnering, and mergers and acquisitions, with a focus on creating and implementing corporate strategies.

Richard Waldron holds an AB in Economics from Princeton University and pursued an MBA with a focus on Management and Finance at Harvard Business School.

Throughout his career, he has held key positions such as Senior Vice President and Chief Financial Officer at BioAtla LLC, as well as various roles in organizations like Intrexon Corporation, SciClone Pharmaceuticals, and GeneMedicine, Inc.

Additionally, he has worked as a Managing Director at Rauscher Pierce Refsnes, which was later known as RBC Capital Markets, and as a Senior Vice President at Cowen and Company.